Student Name Western Governors University D115 Advanced Pathophysiology for the Advanced Practice Nurse Prof. Name Date Unit 6: Renin–Angiotensin–Aldosterone System (RAAS) Purpose and Physiological Importance The Renin–Angiotensin–Aldosterone System (RAAS) is a vital hormonal mechanism that plays a key role in regulating systemic blood pressure, maintaining extracellular fluid volume, and balancing electrolytes. This system acts primarily as a compensatory response to conditions such as decreased renal blood flow, low blood pressure, or reduced sodium levels. By doing so, it helps restore and maintain hemodynamic stability and homeostasis. What Stimulates RAAS Activation? RAAS is triggered when the kidneys sense specific physiological changes, including: These signals prompt the body to conserve sodium and water, aiding in the restoration of adequate blood pressure and tissue perfusion. Stepwise Mechanism of RAAS Activation The RAAS involves a multi-organ cascade described as follows: Step Organ/Site Action 1 Liver Produces and releases angiotensinogen into the bloodstream. 2 Kidney (juxtaglomerular cells) Secretes renin in response to low perfusion. 3 Blood Renin converts angiotensinogen into angiotensin I. 4 Lungs (pulmonary endothelium) ACE converts angiotensin I to angiotensin II. 5 Adrenal cortex Releases aldosterone under stimulation by angiotensin II. 6 Kidneys and blood vessels Aldosterone promotes sodium retention; angiotensin II causes vasoconstriction. Physiological Effects of Angiotensin II Angiotensin II, the main effector hormone, produces multiple effects: Acute Pyelonephritis What Is Acute Pyelonephritis? Acute pyelonephritis is an infection that affects one or both kidneys, specifically targeting the renal pelvis, calyces, interstitial tissue, and renal tubules. It is a severe type of upper urinary tract infection that can lead to significant renal damage if untreated. Who Is Susceptible? Risk factors that predispose individuals include: Which Microorganisms Cause It? The infection usually arises from bacteria traveling upward from the lower urinary tract, most commonly: What Are the Pathological Changes? The infection mainly harms renal tubules, leading to: What Are the Symptoms? Typical clinical features include: How Is It Diagnosed and Treated? Diagnosis relies on urinalysis and urine culture; the presence of white blood cell casts strongly suggests renal involvement. Blood cultures and imaging may be required for complicated cases. Treatment involves targeted antibiotics for 2 to 3 weeks, with follow-up cultures if symptoms persist or recur. Acute Glomerulonephritis What Is Acute Glomerulonephritis? Acute glomerulonephritis is characterized by inflammation and injury to the glomeruli. It may occur as a primary kidney disorder or secondary to systemic conditions. What Causes It? The condition can result from: How Does It Affect the Kidney? Inflammation compromises the glomerular filtration barrier (including endothelial cells, basement membrane, and podocytes), causing reduced filtration efficiency and progressive nephron damage. What Is the Clinical Course? Symptoms often develop slowly, allowing significant renal injury before detection. Severe cases may present with decreased urine output (oliguria) and rapid kidney function decline. Diabetes Insipidus: Diagnosis and Management How Is Diabetes Insipidus Diagnosed? The desmopressin (ADH analog) test differentiates between two forms of diabetes insipidus (DI): Type of DI Response to Desmopressin Neurogenic (central) Increase in urine osmolality Nephrogenic No significant change in urine osmolality What Are the Treatment Approaches? Neurogenic DI: Nephrogenic DI: Gastroesophageal Reflux Disease (GERD) What Is GERD? GERD is a chronic condition where acidic stomach contents reflux into the esophagus, causing mucosal injury and inflammation. How Does GERD Develop? The primary mechanism involves the failure of the lower esophageal sphincter (LES) to maintain sufficient tone. This allows acid and pepsin reflux, either due to transient LES relaxations or structural weakness. What Factors Worsen GERD? Increased intra-abdominal pressure from obesity, pregnancy, coughing, vomiting, or heavy lifting can exacerbate reflux. What Symptoms Are Common? How Is GERD Diagnosed? Upper endoscopy with biopsy is the main diagnostic tool to assess mucosal damage and exclude premalignant conditions like Barrett’s esophagus. What Treatments Are Available? Treatment Category Description First-line Proton pump inhibitors (e.g., omeprazole) Second-line H2 receptor antagonists (e.g., famotidine) Adjunctive Antacids, prokinetics Lifestyle Weight loss, dietary changes, bed elevation Surgical Laparoscopic fundoplication for refractory cases Glomerulonephritis Overview What Is Glomerulonephritis? Glomerulonephritis refers to a group of inflammatory disorders targeting the kidney’s glomeruli, leading to impaired filtration and fluid regulation. What Are the Types and Causes? Type Features Acute Sudden onset, often following infection Chronic Progressive deterioration leading to CKD Common causes include infections, autoimmune diseases, drug toxicity, hypertension, diabetes, genetic factors, and malignancies. What Are the Clinical Features? How Is It Diagnosed and Managed? Diagnosis involves laboratory tests, imaging, and renal biopsy. Treatment varies from antibiotics to immunosuppressants, with blood pressure control and dietary management. Advanced cases may require dialysis or transplantation. Nephrotic Syndrome Definition and Characteristics Nephrotic syndrome is marked by heavy proteinuria (>3.5 g/day), hypoalbuminemia, generalized edema, and hyperlipidemia. Pathophysiology Damage to the glomerular filtration barrier increases permeability, allowing albumin loss and resulting in decreased plasma oncotic pressure. This leads to fluid shifting into tissues and activation of RAAS, worsening edema. Types and Causes Primary causes include minimal change disease and focal segmental glomerulosclerosis, while secondary causes involve diabetes, amyloidosis, infections, and systemic illnesses. What Complications Arise? Patients face heightened risks of infections, thromboembolism, nutritional deficits, and cardiovascular problems. Management Strategies Dietary Management Pharmacologic Therapy Complication Management Peptic Ulcer Disease (PUD) Overview What Is PUD? Peptic ulcer disease consists of mucosal erosions or ulcers in the lower esophagus, stomach, or duodenum due to acid and pepsin injury. What Are the Risk Factors? What Are the Types and Symptoms? Ulcer Type Location Characteristic Features Gastric Stomach Pain worsens after eating, weight loss, early satiety Duodenal Duodenum Pain relieved by food, often nocturnal Esophageal Esophagus Associated with GERD symptoms, dysphagia How Is It Diagnosed? Upper gastrointestinal endoscopy allows direct visualization and biopsy. Testing for H. pylori includes tissue biopsy or stool antigen assays. Blood tests help identify anemia from chronic bleeding. What Treatments Are Recommended? Condition Treatment Approach H. pylori-positive ulcers Clarithromycin-based triple therapy or bismuth-based quadruple therapy with PPIs H. pylori-negative ulcers Proton pump inhibitors for 6–8 weeks, avoidance of ulcerogenic drugs Lifestyle modifications include avoiding NSAIDs, alcohol, and smoking, with surgery reserved for complicated or refractory cases. Overview of Pyelonephritis What Is Pyelonephritis? Pyelonephritis is an

Student Name Western Governors University D115 Advanced Pathophysiology for the Advanced Practice Nurse Prof. Name Date Hypertension What is Hypertension? Hypertension is characterized by a persistent elevation in systemic arterial blood pressure. According to the 2014 guidelines, hypertension is diagnosed when systolic blood pressure is 140 mmHg or higher, or diastolic blood pressure is 90 mmHg or higher. The 2017 updated guidelines lowered these thresholds to a systolic pressure of 130 mmHg or above and a diastolic pressure of 80 mmHg or above, reflecting growing evidence on cardiovascular risk at lower blood pressure levels. What is the Epidemiology of Hypertension? Hypertension is the most prevalent primary diagnosis in the United States, affecting a significant portion of the population. Approximately 95% of hypertension cases are classified as primary (essential) hypertension, where no specific cause can be identified. Secondary hypertension, accounting for roughly 5% of cases, is due to underlying conditions such as kidney disease. What Types of Hypertension Exist? Type Characteristics Cause Outcome Primary (Essential) No identifiable cause; caused by genetic and environmental factors Genetic and environmental interactions Leads to increased vascular tone and blood volume, causing sustained high blood pressure Secondary Resulting from specific disease (e.g., renal disorders) Increased peripheral resistance or cardiac output Potentially reversible with early treatment What Are the Risk Factors for Primary Hypertension? Risk factors are divided into three broad categories: These factors are also significant contributors to cardiovascular disease risk. What is the Pathophysiology of Hypertension? Hypertension results from increased cardiac output, increased total peripheral resistance, or both. Persistent high blood pressure can cause damage to vital organs over time. What are the Clinical Manifestations of Hypertension? Hypertension is often called the “silent disease” because it usually lacks symptoms initially. Symptoms appear when target organs are affected and may include coronary heart disease, heart failure, kidney failure, stroke, cognitive impairment, visual disturbances, edema, or vascular occlusions. How is Hypertension Diagnosed? Diagnosis requires blood pressure measurement on at least two separate occasions, averaging two readings taken two minutes apart. Proper measurement technique is critical—patients should be seated comfortably, with the arm at heart level, rested, and without recent caffeine or smoking. How is Hypertension Managed? Management involves lifestyle changes such as diet modification, exercise, and stress reduction. Pharmacologic treatment is guided by the severity of hypertension and current clinical guidelines. Metabolic Syndrome What is Metabolic Syndrome? Metabolic syndrome is a constellation of metabolic abnormalities that greatly increase the risk of developing type 2 diabetes and cardiovascular diseases. What are the Components of Metabolic Syndrome? Component Central (abdominal) obesity Dyslipidemia Prehypertension Elevated fasting blood glucose What is the Epidemiology of Metabolic Syndrome? The syndrome may begin in childhood and is common among sedentary adults and overweight youth, highlighting the importance of early detection and intervention. How is Metabolic Syndrome Managed? Routine screening and early identification are critical. Management focuses on aggressive lifestyle modifications, emphasizing weight loss, a healthy diet, and increased physical activity. Deep Vein Thrombosis (DVT) What is Deep Vein Thrombosis? DVT is a venous thrombus that remains attached to the vessel wall, predominantly occurring in the lower extremities. What are the Risk Factors for DVT? Risk Factor Hospitalization Trauma Orthopedic surgery Age over 60 Pregnancy Malignancy Inherited thrombophilias (e.g., Factor V Leiden) What is the Pathophysiology of DVT? DVT develops through venous stasis, endothelial injury, and a hypercoagulable state, collectively known as Virchow’s triad. Clot formation progresses, especially near venous valves. What are the Clinical Manifestations of DVT? DVT may be asymptomatic but can present with unilateral limb pain, swelling, dilated superficial veins, or skin discoloration. How is DVT Diagnosed? A D-dimer test, which is highly sensitive but not specific, is often the initial screening tool. Definitive diagnosis is made with compression Doppler ultrasound. What are the Prevention and Treatment Strategies for DVT? Prevention includes early mobilization and use of compression devices in high-risk patients. Treatment involves anticoagulation therapy tailored to the patient’s risk profile. Angina Pectoris What is Angina Pectoris? Angina pectoris is chest pain resulting from myocardial ischemia. What Types of Angina Exist? Type Description Clinical Features Treatment Stable Angina Predictable and occurs with exertion Relieved by rest; no myocardial necrosis Lifestyle changes, nitrates Unstable Angina Occurs at rest or with increasing frequency Associated with plaque rupture; risk of MI Urgent medical treatment Prinzmetal (Variant) Angina Caused by coronary vasospasm Occurs at rest, often nocturnal Calcium channel blockers, nitrates Heart Failure What is Heart Failure? Heart failure is the inability of the heart to maintain adequate cardiac output or filling pressures. What are the Types of Heart Failure? Type Features Left-sided Systolic (HFrEF) EF < 40%, impaired myocardial contractility Left-sided Diastolic (HFpEF) Normal EF, impaired relaxation of the heart Right-sided Heart Failure Usually secondary to left-sided failure; causes systemic venous congestion Cardiogenic Shock What is Cardiogenic Shock? Cardiogenic shock is a condition where the heart fails to pump enough blood despite normal filling pressures. What are the Clinical Features of Cardiogenic Shock? Symptoms include hypotension, tachycardia, dyspnea, and reduced organ perfusion leading to potential multi-organ failure.Hypoplastic Left Heart Syndrome (HLHS) What is HLHS? HLHS is a congenital defect characterized by underdevelopment of the left heart structures, resulting in insufficient systemic blood flow. How Does HLHS Present? Infants may appear normal at birth but rapidly deteriorate once the ductus arteriosus closes. How is HLHS Managed? Treatment involves prostaglandin infusion to keep the ductus arteriosus open, followed by staged surgical palliation through Norwood, Glenn, and Fontan procedures. Hematologic Disorders What are Some Key Hematologic Disorders? Disorder Description Key Features Sickle Cell Disease Autosomal recessive hemoglobinopathy causing vaso-occlusion and hemolysis Chronic organ damage due to sickled RBCs Disseminated Intravascular Coagulation (DIC) Systemic activation of coagulation and fibrinolysis Leads to simultaneous thrombosis and bleeding Pernicious Anemia Vitamin B12 deficiency due to intrinsic factor loss Causes megaloblastic anemia and neurologic symptoms Iron Deficiency Anemia Most common anemia worldwide, caused by blood loss or poor intake Microcytic, hypochromic red blood cells What Are Leukemias? Type Characteristics Common Demographics Acute Leukemias Proliferation of immature blasts ALL in children; AML

Student Name Western Governors University D115 Advanced Pathophysiology for the Advanced Practice Nurse Prof. Name Date D115 Unit 3 Videos: Bacterial Meningitis & Neurologic System Alterations Bacterial Meningitis What is Bacterial Meningitis?Bacterial meningitis is the inflammation of the meninges, which are the pia mater and arachnoid mater membranes that encase the brain and spinal cord. This condition can arise from infections by bacteria, viruses, fungi, parasites, toxins, or even noninfectious causes. Which Pathogens Are Most Common?The primary bacterial agents causing meningitis include: Pathogen Notes Neisseria meningitidis (meningococcus) Leading cause in many populations Streptococcus pneumoniae (pneumococcus) Common with increasing drug resistance Who is at Risk?Populations most vulnerable include: Settings prone to outbreaks include college dormitories, military bases, and regions in Sub-Saharan Africa. What Are Predisposing Factors?Conditions that increase susceptibility are: How is it Transmitted?Bacterial meningitis spreads through respiratory droplets or saliva, commonly through close contact such as kissing, coughing, sneezing, or sharing food and drinks. Asymptomatic carriers can also transmit the infection. What Happens in the Body? (Pathophysiology)Bacteria enter through the respiratory tract or bloodstream, possibly via neurosurgical interventions. They cross the blood-brain barrier, multiply in cerebrospinal fluid (CSF), and release toxins that increase vascular permeability, causing cerebral edema. Obstruction of CSF flow leads to raised intracranial pressure, which can cause brainstem herniation and death. What Are the Clinical Features? Symptom Category Symptoms Systemic Signs Fever, chills, tachycardia Meningeal Signs Severe headache, photophobia, nuchal rigidity, positive Kernig and Brudzinski signs Neurologic Signs Reduced consciousness, seizures, hemiparesis, confusion, projectile vomiting, papilledema, petechial rash, bulging fontanels (infants), opisthotonic posturing (children) How is it Diagnosed?Diagnosis involves lumbar puncture revealing increased white blood cells in CSF, alongside blood cultures to identify the causative organism. What is the Treatment?Empiric intravenous antibiotics should be initiated immediately, followed by adjustment based on culture results. Dexamethasone is recommended in pneumococcal meningitis, supplemented by supportive care. What Complications Can Occur?Potential serious outcomes include septic shock, disseminated intravascular coagulation (DIC), purpura fulminans, and multi-organ failure. How Can It Be Prevented?Vaccination against meningococcal, pneumococcal, and Haemophilus influenzae type B bacteria plays a critical role in prevention. Guillain-Barré Syndrome (GBS) What is Guillain-Barré Syndrome?GBS is an acute autoimmune condition targeting the peripheral nervous system, leading to demyelination and ascending muscle weakness. What Causes GBS?Often, GBS follows infections or immune system activations caused by agents such as Campylobacter jejuni, cytomegalovirus (CMV), Epstein-Barr virus (EBV), influenza, Mycoplasma pneumoniae, and Zika virus. It may also be triggered by surgery or immunization. What is the Underlying Mechanism?Molecular mimicry causes antibodies to attack peripheral nerve myelin or axons, and complement activation impairs nerve conduction. What Are the Subtypes of GBS? Subtype Description Acute inflammatory demyelinating polyneuropathy Most common variant Acute motor axonal neuropathy Involves motor nerves Acute motor-sensory axonal neuropathy Affects both motor and sensory nerves Miller Fisher syndrome Rare; characterized by ataxia, ophthalmoplegia, and areflexia What Symptoms Does GBS Present?Patients develop ascending flaccid paralysis, paresthesia, muscle weakness, areflexia, autonomic instability, and may progress to respiratory muscle paralysis within two weeks. How is GBS Diagnosed?The diagnosis requires progressive weakness in at least two limbs, areflexia, and symptom progression over less than four weeks. What Treatment Options Exist?Treatment includes intravenous immunoglobulin (IVIG), plasmapheresis, and aggressive rehabilitation. What is the Prognosis?Recovery may span weeks to months, sometimes up to two years, with approximately 30% of patients experiencing residual weakness. Multiple Sclerosis (MS) What Defines Multiple Sclerosis?MS is a chronic autoimmune disorder characterized by demyelination in the central nervous system (CNS). What is the Pathophysiology?Activated T-cells penetrate the blood-brain barrier, releasing cytokines that damage oligodendrocytes. This results in demyelinated plaques visible on MRI. While early remyelination occurs, it diminishes over time. Who is at Risk?Risk factors include: What Types of MS Exist? Type Description Relapsing-remitting Most common form, characterized by flare-ups and remissions Secondary progressive Initially relapsing-remitting, then steadily worsening Primary progressive Continuous worsening from onset Progressive-relapsing Steady decline with acute relapses What Are Common Symptoms?Between ages 20 and 40, patients commonly experience motor symptoms (weakness, tremor, spasticity, ataxia), sensory changes (numbness, paresthesia), visual disturbances (optic neuritis, diplopia), speech difficulties (dysarthria), autonomic dysfunction, and cognitive issues including depression and impaired concentration. Charcot’s triad of dysarthria, nystagmus, and intention tremor is a hallmark. How is MS Diagnosed?Diagnosis is based on MRI showing CNS plaques, CSF analysis revealing oligoclonal bands, visual evoked potentials, and clinical evidence of symptoms separated in time and space. What Treatments Are Available?Acute exacerbations are managed with corticosteroids, IVIG, or plasmapheresis. Disease-modifying therapies include interferon-beta and immunosuppressants. Rehabilitation addresses symptoms and functional impairment. Myasthenia Gravis What is Myasthenia Gravis?A chronic autoimmune disorder leading to fluctuating skeletal muscle weakness due to impaired neuromuscular transmission. What Causes It?Autoantibodies target and destroy acetylcholine receptors at the neuromuscular junction, disrupting communication between nerves and muscles. What Symptoms Are Characteristic?Typical signs include ptosis, diplopia, facial weakness, difficulty chewing, swallowing, and speaking, limb and neck weakness, with symptoms improving after rest. How is Diagnosis Made? Diagnostic Tool Purpose Acetylcholine receptor antibodies Detect autoantibodies Anti-MuSK antibodies Alternative antibody detection Electromyography (EMG) Assess neuromuscular transmission Edrophonium test Temporary symptom improvement test CT/MRI Identify thymoma if present What Are Treatment Approaches?Management includes anticholinesterase medications, immunosuppressants, thymectomy if thymoma is present, and IVIG or plasmapheresis during exacerbations. Diabetes Mellitus OverviewDiabetes Mellitus is a metabolic disease marked by chronic high blood glucose levels due to either insufficient insulin production or resistance to insulin action. How Is Blood Sugar Regulated?Insulin lowers blood glucose, whereas glucagon raises it. Both hormones are produced in pancreatic islets. Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus How is Diabetes Diagnosed? (WHO Criteria) Test Diagnostic Threshold Fasting glucose ≥126 mg/dL Random glucose ≥200 mg/dL Oral glucose tolerance test (OGTT) ≥200 mg/dL at 2 hours HbA1c ≥6.5% Hyperparathyroidism What is Hyperparathyroidism?It is characterized by excessive secretion of parathyroid hormone (PTH), causing elevated calcium levels in the blood. What Are the Types? Type Cause Primary Parathyroid adenoma or hyperplasia Secondary Chronic hypocalcemia from chronic kidney disease or vitamin D deficiency Tertiary Autonomous PTH secretion after prolonged secondary hyperparathyroidism What Symptoms Occur?Common manifestations include kidney stones, bone pain, fractures, osteoporosis, gastrointestinal disturbances (constipation, nausea),

Student Name Western Governors University D115 Advanced Pathophysiology for the Advanced Practice Nurse Prof. Name Date Unit 2: Genetic Testing and Genetic Disorders Genetic Testing Overview Genetic testing encompasses a variety of laboratory methods aimed at detecting genetic variations that influence disease risk, diagnosis, prognosis, and response to treatment. With progress in molecular genetics, it has become possible to pinpoint individuals who are predisposed to both complex multifactorial diseases and single-gene disorders. These tests have become integral in preventive healthcare, reproductive decision-making, and tailoring medical treatments to the individual. Types of Genetic Testing What is Carrier Screening? Carrier screening is a type of genetic test that identifies people who carry one copy of a gene mutation for autosomal recessive disorders. While carriers usually do not exhibit symptoms, they have the potential to pass the genetic mutation to their children. This testing is particularly important for prospective parents, especially in populations where certain inherited diseases are more common. Common Disorders Detected Through Carrier Screening Disorder Inheritance Pattern Population Significance Cystic fibrosis Autosomal recessive Predominantly in individuals of European descent Sickle cell disease Autosomal recessive Common among individuals of African ancestry Tay-Sachs disease Autosomal recessive Prevalent in Ashkenazi Jewish populations Carrier screening empowers couples with knowledge about their genetic risks, enabling more informed reproductive choices. What is Prenatal Diagnosis? Prenatal diagnosis involves testing during pregnancy to assess the genetic health of the fetus. It is advised for all pregnant individuals, especially those with risk factors such as advanced maternal age, a family history of genetic diseases, or abnormal prenatal screening results. Common Prenatal Diagnostic Techniques Method Description Amniocentesis Sampling fetal cells from amniotic fluid Chorionic Villus Sampling (CVS) Sampling placental tissue Preimplantation Genetic Diagnosis (PGD) Genetic testing of embryos during IVF Cell-Free Fetal DNA Testing Analyzing fetal DNA present in maternal blood These procedures enable early detection of chromosomal abnormalities and inherited conditions, facilitating timely counseling and medical management. What is Presymptomatic Genetic Testing? Presymptomatic testing identifies individuals who carry mutations linked to adult-onset genetic disorders before symptoms arise. Examples include mutations in BRCA genes associated with hereditary breast cancer and genetic variants linked to familial colon cancer. Early detection allows for enhanced monitoring, preventive measures, and lifestyle changes that can improve outcomes. What is Pharmacogenetic Testing? Pharmacogenetic testing explores genetic differences that influence how patients respond to medications. By understanding these variations, healthcare providers can customize drug prescriptions to improve efficacy, minimize adverse reactions, and optimize overall treatment strategies. Reasons for Genetic Screening Purpose Clinical Importance Predicting disease risk Identifies individuals with increased susceptibility Early diagnosis Facilitates timely medical intervention Reducing risk Enables implementation of preventive actions Guiding drug therapy Supports personalized medicine approaches Chromosomal Aneuploidy Disorders Turner Syndrome What is Turner Syndrome and How Common Is It? Turner syndrome is a chromosomal condition caused by monosomy X (45,X), where one X chromosome is missing, leading to females who are phenotypically female but with specific developmental issues. It affects about 1 in every 2,500 female births and was first described by Dr. Henry Turner in 1938. What Causes Turner Syndrome? The syndrome results from the absence or structural abnormality of one X chromosome. Individuals typically have nonfunctional ovaries, replaced by fibrous tissue (gonadal streaks) that do not produce estrogen or progesterone, causing impaired sexual development and infertility. Some have mosaicism with mixed cell lines, which may result in milder symptoms and improved survival. What Are the Clinical Features of Turner Syndrome? System Affected Common Manifestations Growth Short stature Cardiovascular Coarctation of the aorta Reproductive Primary amenorrhea, infertility Skeletal Osteoporosis Cognitive Generally normal IQ, some spatial reasoning difficulties How is Turner Syndrome Diagnosed and Managed? Diagnosis relies on karyotyping of blood cells. Treatment involves hormone replacement (estrogen and growth hormone), fertility counseling, and ongoing multidisciplinary care to monitor and address associated health issues. Klinefelter Syndrome What Is Klinefelter Syndrome and Its Prevalence? Klinefelter syndrome is characterized by males having one or more extra X chromosomes, most commonly 47,XXY. It occurs in about 1 in 1,000 male births. The presence of additional X chromosomes often correlates with more severe physical and cognitive impairments. What Are the Signs of Klinefelter Syndrome? Individuals often have small testes, infertility, breast tissue development (gynecomastia), sparse body hair, taller stature, and varying degrees of cognitive challenges. Mosaic forms may show less severe symptoms. Cri du Chat Syndrome (5p Deletion Syndrome) What Genetic Change Causes Cri du Chat Syndrome? This syndrome results from the deletion of part of the short arm of chromosome 5, with severity depending on the extent of the deletion. Most cases arise sporadically, though some are inherited. What Are the Key Clinical Features? Feature Description Cry High-pitched, cat-like cry Neurological Severe intellectual disability Craniofacial Small head (microcephaly), small jaw (micrognathia) Musculoskeletal Low muscle tone (hypotonia) Cardiac Congenital heart defects Diagnosis is confirmed via cytogenetic testing. Treatment is supportive, including therapies to improve physical, occupational, and speech skills. Down Syndrome (Trisomy 21) What Causes Down Syndrome? Down syndrome is caused by an extra copy of chromosome 21, making it the most common autosomal aneuploidy compatible with life, affecting approximately 1 in 800 live births. What Are the Clinical Characteristics? Category Findings Cognitive Intellectual disability with IQ typically between 25 and 70 Facial Flat nasal bridge, epicanthal folds Cardiac Congenital heart defects Immune Increased susceptibility to infections Neurological Alzheimer-like changes by mid-adulthood Immunity and Genetic Influence What Constitutes Innate Immunity? Innate immunity acts as the body’s immediate defense, present from birth. It includes physical barriers such as skin and mucous membranes, mechanical defenses like coughing and urination, biochemical agents such as stomach acid and lysozyme, and immune cells including neutrophils, macrophages, natural killer cells, and dendritic cells. Inflammation is a hallmark response, characterized by redness, warmth, swelling, and pain. What Is Adaptive Immunity? Adaptive immunity develops over time and provides targeted responses against specific pathogens. It involves humoral immunity through B cells producing antibodies, and cell-mediated immunity via T cells. Memory cells generated during this process ensure long-lasting protection after exposure to infections or vaccinations. Inheritance

Student Name Western Governors University D115 Advanced Pathophysiology for the Advanced Practice Nurse Prof. Name Date D115 Practice Questions 3: Essential Concepts in Immunology and Disease a. Sizeb. Complexityc. Quantityd. Foreignness a. It involves a lag or latent period.b. IgM is the predominant antibody produced.c. There is a significant increase in IgG levels.d. Memory cells need to be generated first. a. NK cells only induce apoptosis independently.b. NK cells target abnormal cells expressing MHC class I molecules.c. NK cells lack antigen-specific receptors.d. NK cells mature in the thymus gland. a. An immune response against tissues from another person.b. Loss of tolerance to the body’s own antigens.c. Exposure to environmental antigens.d. Development of an anaphylactic reaction. a. Antibodies attach to tissue-specific antigens.b. Immune complexes deposit in blood vessel walls.c. T lymphocytes drive the immune response, not antibodies.d. IgE and mediators released from mast cells play a central role. a. Self-antigens trigger molecular mimicry.b. Transplanted tissues are rejected by the immune system.c. The immune system mistakenly attacks the body’s own antigens.d. An acute transplant rejection occurs. a. Excessive zinc intake in the diet.b. Caring for an elderly parent with Alzheimer’s disease.c. Use of aspirin as prescribed by a doctor.d. Congenital or genetic defects in newborns. a. Through natural killer cell activity.b. By macrophage phagocytosis.c. Via phagocytosis within the spleen.d. Through complement system-mediated cell lysis. a. 1 to 2 daysb. 4 to 10 daysc. 4 to 8 weeksd. 2 to 4 months a. They are released during bacterial cell breakdown.b. They are components of gram-negative bacterial cell walls.c. They can trigger complement and coagulation pathways.d. They are secreted during bacterial growth. a. Convalescent stageb. Incubation stagec. Prodromal staged. Invasive stage a. Parasites attach to host cells using pili (fimbriae).b. Candida albicans is classified as a parasitic infection.c. Parasites are transmitted only from person to person.d. Malaria is a common parasitic disease. a. The person has sufficient helper T cell counts.b. The person is HIV-positive but asymptomatic.c. The person is in early HIV infection stages.d. The person’s condition has progressed to AIDS. a. By protecting bacterial cell walls.b. By blocking protein synthesis in bacteria.c. By enhancing bacterial DNA replication.d. By promoting folic acid production in bacteria. a. Eating more dairy productsb. Reducing intake of high-fat foodsc. Increasing foods rich in vitamin Cd. Avoiding artificial food colorings a. Bladder cancerb. Leukemiac. Stomach cancerd. Lung cancer

Student Name Western Governors University D115 Advanced Pathophysiology for the Advanced Practice Nurse Prof. Name Date PHASE 1: USING THE FEYNMAN TECHNIQUE TO LEARN AND TEACH PATHOPHYSIOLOGY What activities are involved in Phase 1, and how should they be organized? Phase 1 starts with a comprehensive review of all Clinical Practice Experience (CPE) requirements, which span three distinct phases. It is essential to break down the overall workload into smaller, manageable tasks, each with its own deadline to ensure timely completion. A detailed schedule should be created and maintained in an e-portfolio. This schedule lists every task, its due date, and an estimate of the time needed to finish it. This structured approach supports efficient time management throughout the CPE, helping learners stay on track (10/7/2024, 25 minutes). How do I apply the Feynman technique to synthesize knowledge of a disease commonly seen in primary care? The Feynman technique requires students to write down their current understanding of a disease’s pathophysiology, clinical symptoms, and diagnostic methods. One disease is selected from common primary care conditions such as upper respiratory infection, hypertension, osteoarthritis, diabetes, depression, anxiety, pneumonia, acute otitis media, back pain/strain, atopic dermatitis, urinary tract infection, or asthma. This knowledge is then deepened using textbooks, course content, and credible online resources. The next step involves creating a one-page, single-spaced summary that explains the disease in simple terms as if teaching someone without medical knowledge. It is crucial that all sources are cited in APA format and that this synthesis is uploaded to the e-portfolio (10/13/2024, 2-3 hours). How should I assess and improve my synthesis? After drafting the synthesis, a self-assessment focusing on both clarity and accuracy is recommended. Learners should document their reflections, noting what parts may need refinement. Using this feedback, revisions should be made to improve the quality and comprehension of the synthesis before final submission to the e-portfolio (10/13/2024, 1 hour). What is involved in the GoReact video reflection? A key part of Phase 1 is recording a 3 to 5-minute video reflecting on the learning journey. This includes discussing the steps taken, knowledge gained, challenges faced during self-assessment, and how feedback was used for improvement. After posting the video, participants watch and critique two peers’ reflections, providing constructive feedback. Screenshots of the learner’s own video and peer responses are then included in the portfolio for documentation (1/16/2025, 1 hour). What evidence should be included in the e-portfolio for Phase 1? The portfolio for Phase 1 must contain the following: PHASE 1 CPE SCHEDULE TABLE Task Proposed Completion Date Actual Completion Date Estimated Time Review CPE requirements and plan 10/7/2024 10/7/2024 25 minutes Write Feynman synthesis 10/10/2024 10/13/2024 2-3 hours Self-assessment and revision 10/13/2024 10/13/2024 1 hour GoReact video reflection 1/16/2025 1/16/2025 1 hour PHASE 1 FEYNMAN SIMPLIFIED SYNTHESIS: HYPERTENSION What is hypertension?Hypertension is defined as persistently elevated blood pressure, which is the force blood exerts against arterial walls. The normal blood pressure reading is around 120/80 mmHg. Hypertension is categorized into two stages: Stage 1 involves systolic pressure between 130-139 mmHg or diastolic between 80-89 mmHg; Stage 2 includes readings at or above 140/90 mmHg. This condition often develops gradually and is influenced by genetics, poor dietary habits, sedentary lifestyle, and smoking (Huether & McCance, 2019). What are the clinical signs?In its early phases, hypertension usually presents no symptoms. When symptoms do occur, they often reflect complications such as kidney dysfunction, vision problems, swelling (edema), neurological symptoms, or vascular blockages (Centers for Disease Control and Prevention [CDC], n.d.; Huether & McCance, 2019). How is hypertension diagnosed?Diagnosis involves a thorough medical history, physical examination, and family history review. Blood pressure measurements should be taken multiple times under controlled conditions, such as resting for five minutes before measurement and avoiding caffeine or smoking beforehand. Ambulatory blood pressure monitoring over 24 hours can differentiate between “white-coat” hypertension and “masked” hypertension. Additional lab tests (e.g., electrolytes, glucose, urinalysis, thyroid function, lipid profile) and ECG are used to assess for secondary causes and detect organ damage (Huether & McCance, 2019; Block & Badile, 2024). PHASE 2: REFINEMENT WITH ADVANCED PROFESSIONAL FEEDBACK What steps are taken in Phase 2? Phase 2 begins with revisiting and updating the CPE plan to reflect ongoing progress and upcoming activities. The schedule should be revised accordingly to maintain effective time management (10/7/2024, 25 minutes). How do I collaborate with advanced nurses or colleagues? The initial Feynman synthesis is presented to experienced nurses or healthcare professionals for critique. Specific feedback is requested regarding the clarity of explanations, accuracy of content, and helpful analogies. All feedback is recorded alongside a description of intended revisions. This collaborative input is used to improve the synthesis, which is then uploaded in its refined form to the e-portfolio (10/13/2024, 1 hour). What should be included in the GoReact reflection for Phase 2? In this phase, a 3 to 5-minute video is created reflecting on the feedback process, new insights, challenges faced in presenting the material, and how suggestions influenced revisions. Participants also watch two peer videos and provide feedback. Screenshots from these interactions are saved for portfolio inclusion (1/16/2025, 45 minutes). What evidence is required for Phase 2? The evidence should include: PHASE 2 CPE SCHEDULE TABLE Task Proposed Completion Date Actual Completion Date Estimated Time Review and plan Phase 2 10/7/2024 10/7/2024 25 minutes Presentation and feedback 10/13/2024 10/13/2024 1 hour GoReact video reflection 1/16/2025 1/16/2025 45 minutes PHASE 2 REFINED SYNTHESIS: HYPERTENSION (EXPANDED) Definition and PathophysiologyHypertension is characterized by persistently elevated arterial blood pressure exerting force against the walls of blood vessels. Normal blood pressure is considered around 120/80 mmHg, with Stage 1 hypertension defined as systolic 130-139 mmHg and/or diastolic 80-89 mmHg, and Stage 2 as systolic ≥140 mmHg and/or diastolic ≥90 mmHg. Genetic predisposition, lifestyle factors such as poor diet and inactivity, and environmental influences contribute to its development. Chronic hypertension increases the risk of cardiovascular events and damage to organs like the heart, kidneys, and brain (Huether & McCance, 2019). SymptomsEarly hypertension is generally asymptomatic.